Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis

被引：17
|
作者：
Sedeno-Monge, Virginia [1 ]
Arcega-Revilla, Raul [2 ]
Rojas-Morales, Emmanuel [3 ]
Santos-Lopez, Gerardo [4 ]
Carlos Perez-Garcia, Juan [1 ]
Sosa-Jurado, Francisca [4 ]
Vallejo-Ruiz, Veronica [4 ]
Solis-Morales, Casandra Lucrecia
Aguilar-Rosas, Salvador [5 ]
Reyes-Leyva, Julio [4 ]
机构：
[1] Univ Popular Autonoma Estado Puebla, Fac Med, Puebla, Mexico
[2] Inst Mexicana Seguro Social, Hosp Especialidades, UMAE, Serv Neurol, Puebla, Mexico
[3] Univ Politecn Puebla, Puebla, Mexico
[4] Inst Mexicano Seguro Social, Ctr Invest Biomed Oriente, Lab Biol Mol & Virol, Puebla, Mexico
[5] Univ Popular Autonoma Estado Puebla, Dept Ciencias Biol, Puebla, Mexico
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 273卷 / 1-2期
关键词：
Multiple sclerosis; IFN-beta; SOCS1; SOCS3; INTERFERON-GAMMA; DISEASE-ACTIVITY; EXPRESSION; CELLS; INHIBITOR; PREVENTS; BETA; MICE; ENCEPHALOMYELITIS; OLIGODENDROCYTES;
D O I：
10.1016/j.jneuroim.2014.05.013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Multiple sclerosis (MS) is an autoimmune disease characterized by a triad of inflammation, demyelination and gliosis. Because the suPpressors of cytokine signaling (Socs) regulate the immune response, we quantified SOCS1 and SOCS3 transcription in peripheral blood leukocytes of patients with MS. SOCS1 transcription decreased significantly in MS patients compared with neurologically healthy persons (0.08 +/- 0.02 vs. 1.02 +/- 0.23; p = 0.0001); while SOCS3 transcription increased in MS patients compared with controls (2.76 +/- 0.66 vs. 1.03 +/- 0.27; p = 0.0008). Our results showed an imbalance of SOCS1 and SOCS3 transcription in MS patients, and a moderated negative correlation between them (Spearman's r = -0.57; p = 0.0003). (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：117 / 119
页数：3
相关论文
共 50 条
  • [21] Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients
    Canto, Ester
    Isobe, Noriko
    Didonna, Alessandro
    Hauser, Stephen L.
    Oksenberg, Jorge R.
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [22] Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients
    Ester Canto
    Noriko Isobe
    Alessandro Didonna
    Stephen L. Hauser
    Jorge R. Oksenberg
    Journal of Neuroinflammation, 15
  • [23] QUANTITATIVE-ANALYSIS OF LEUKOCYTES OF THE HUMAN AND NORMAL PERIPHERAL-BLOOD
    GAUVAIN, C
    BIOLOGY OF THE CELL, 1983, 48 (2-3) : A90 - A90
  • [24] Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
    Akarsu, Ersin
    Sayiner, Zeynel Abidin
    Balci, Sibel Oguzkan
    Demirel, Can
    Bozdag, Zehra
    Korkmaz, Murat
    Yilmaz, Ibrahim
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (01): : 112 - 118
  • [25] Natalizumab treatment modifies peripheral cytokine profile in multiple sclerosis patients
    Balasa, R.
    Bajko, Z.
    Hutanu, A.
    Voidazan, S.
    Maier, S. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 607 - 607
  • [26] TGF-β signaling is altered in the peripheral blood of subjects with multiple sclerosis
    Meoli, Elise M.
    Oh, Unsong
    Grant, Christian W.
    Jacobson, Steven
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 230 (1-2) : 164 - 168
  • [27] ANALYSIS OF ENDOCANNABINOID SYSTEM ELEMENTS AND RELATED INFLAMMATORY MOLECULES IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH SYSTEMIC SCLEROSIS
    Perez-Sanchez, C.
    Ortega-Castro, R.
    del Rio, C.
    Aguirre, M. A.
    Ruiz-Limon, P.
    Barbarroja, N.
    Jimenez-Gomez, Y.
    Arias-de la Rosa, I.
    Abalos-Aguilera, M. C.
    Collantes-Estevez, E.
    Munoz, E.
    Lopez-Pedrera, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 622 - 623
  • [28] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    Schweitzer, F.
    Laurent, S.
    Fink, G. R.
    Barnett, Michael H.
    Hartung, H. P.
    Warnke, C.
    JOURNAL OF NEUROLOGY, 2021, 268 (07) : 2379 - 2389
  • [29] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    F. Schweitzer
    S. Laurent
    G. R. Fink
    Michael H. Barnett
    H. P. Hartung
    C. Warnke
    Journal of Neurology, 2021, 268 : 2379 - 2389
  • [30] Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients
    Christophi, George P.
    Gruber, Ross C.
    Panos, Michael
    Christophi, Rebecca L.
    Jubelt, Burk
    Massa, Paul T.
    CLINICAL IMMUNOLOGY, 2012, 142 (03) : 308 - 319
12345